I
Iovance Biotherapeutics, Inc.
IOVA · NASDAQ · Healthcare · 3.1B
Closing price
$14.62
+9.84% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
7.5×
Enterprise value / EBITDAEV/EBITDA
-14.3×
Free cash flow yieldFCF yield
-6.4%
Return on equityROE
-56.0%
Operating margin
-153.1%
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.